Malta -
Englisch -
Medicines Authority
strattera 18mg hard capsules
eli lilly & co. limited - atomoxetine - hard capsule - atomoxetine 18 mg - psychoanaleptics
Malta -
Englisch -
Medicines Authority
strattera 25mg hard capsules
eli lilly & co. limited - atomoxetine - hard capsule - atomoxetine 25 mg - psychoanaleptics
Malta -
Englisch -
Medicines Authority
strattera 40mg hard capsules
eli lilly & co. limited - atomoxetine - hard capsule - atomoxetine 40 mg - psychoanaleptics
Malta -
Englisch -
Medicines Authority
strattera 60mg hard capsules
eli lilly & co. limited - atomoxetine - hard capsule - atomoxetine 60 mg - psychoanaleptics
Malta -
Englisch -
Medicines Authority
strattera 80mg hard capsules
eli lilly & co. limited - atomoxetine - hard capsule - atomoxetine 80 mg - psychoanaleptics
Malta -
Englisch -
Medicines Authority
strattera 100mg hard capsules
eli lilly & co. limited - atomoxetine - hard capsule - atomoxetine 100 mg - psychoanaleptics
Malta -
Englisch -
Medicines Authority
strattera oral solution 4mg/ml
eli lilly & co. limited - atomoxetine - oral solution - atomoxetine 4 mg/ml - psychoanaleptics
Irland -
Englisch -
HPRA (Health Products Regulatory Authority)
strattera 4 mg/ml oral solution
eli lilly and company limited - atomoxetine hydrochloride - oral solution - 4 mg/ml - centrally acting sympathomimetics
Europäische Union -
Englisch -
EMA (European Medicines Agency)
abasaglar (previously abasria)
eli lilly nederland b.v. - insulin glargine - diabetes mellitus - drugs used in diabetes - treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.
Europäische Union -
Englisch -
EMA (European Medicines Agency)
amyvid
eli lilly nederland b.v. - florbetapir (18f) - radionuclide imaging - diagnostic radiopharmaceuticals - this medicinal product is for diagnostic use only.amyvid is a radiopharmaceutical indicated for positron emission tomography (pet) imaging of β-amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for alzheimer’s disease (ad) and other causes of cognitive impairment. amyvid should be used in conjunction with a clinical evaluation.a negative scan indicates sparse or no plaques, which is not consistent with a diagnosis of ad.